Monoclonal Gammopathy of Ocular Significance – A Case Report
Sadiq Said,Rahel Schwotzer,Daniel Rudolf Muth,Katrin Fasler,Daniel Barthelmes,Sandrine Zweifel,Frank Blaser
DOI: https://doi.org/10.1055/a-2211-9351
2024-04-25
Klinische Monatsblätter für Augenheilkunde
Abstract:Plasma cell dyscrasias are a heterogeneous group of diseases, where clonal expansion of a plasma cell in the bone marrow leads to excessive production of an abnormal nonfunctional immunoglobulin or their parts [1]. In most cases, this monoclonal gammopathy is clinically asymptomatic, without malignancy criteria or the need for therapy. Based on the patient's symptoms, the burden of the monoclonal protein (also called M-protein or paraprotein), and the presence of organ damage, the disease may be classified into the following: monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), Waldenström macroglobulinemia, chronic lymphocytic lymphoma, or other lymphoproliferative disorders [2]. MGUS is the most common plasma cell dyscrasia, affecting approximately 3% of the general population up to age 50, with an even higher prevalence in older individuals [3]. SMM is a premalignant disorder between MGUS and MM [2]. In contrast to MGUS, the degree of plasma cell infiltration in the bone marrow is higher (≥ 10%), which is usually reflected by a higher M-gradient in the serum [4]. Patients with MGUS and SMM are usually asymptomatic and do not display typical myeloma-associated end-organ damage such as anemia, hypercalcemia, lytic bone lesions, or renal failure [2]. Nevertheless, SMM carries a 10% per year risk of progression to symptomatic multiple myeloma over 5 years and a 65% cumulative risk 10 years after diagnosis [5]. Regardless of the disease's dignity and plasma clone size, all plasma cell dyscrasias can cause organ-related complications [6]. As early as 1934, Meesman first reported corneal stromal deposits in a patient with paraproteinemia, whereupon the term paraproteinemic keratopathy (PPK) was introduced [7]. However, because corneal involvement in systemic monoclonal gammopathies is rare and their clinical appearance may resemble other stromal pathologies, initial diagnosis remains challenging. We describe a case of SMM-associated keratopathy diagnosed in a university hospital in Switzerland. Received: 25 October 2023 Accepted: 13 November 2023 Article published online: 23 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
ophthalmology